FYARRO (sirolimus protein-bound particles for injectable suspension) (albumin-bound), FDA Approved for Treatment of Locally Advanced Unresectable or Metastatic Malignant Perivascular Epithelioid Cell Tumor, Available at Biologics by McKesson
Biologics by McKesson was selected as a specialty pharmacy provider for FYARRO, approved for adults with locally advanced unresectable or metastatic malignant PEComa.